Barclays PLC Merrimack Pharmaceuticals Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	SELL	$13.06 - $15.0 $91,837 - $105,480	-7,032 Reduced 48.9%	7,348 $108,000
Q4 2023 Feb 15, 2024	BUY	$12.02 - $13.41 $150,670 - $168,094	12,535 Added 679.4%	14,380 $193,000
Q3 2023 Nov 07, 2023	SELL	$11.6 - $12.52 $43,755 - $47,225	-3,772 Reduced 67.15%	1,845 $23,000
Q2 2023 Aug 03, 2023	BUY	$12.02 - $13.07 $2,151 - $2,339	179 Added 3.29%	5,617 $69,000
Q1 2023 May 04, 2023	BUY	$11.35 - $12.32 $60,189 - $65,332	5,303 Added 3928.15%	5,438 $67,000
Q4 2022 Feb 13, 2023	BUY	$3.68 - $12.51 $496 - $1,688	135 New	135 $2,000
Q2 2021 Aug 13, 2021	SELL	$6.04 - $7.77 $1,932 - $2,486	-320 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$6.15 - $8.7 $1,968 - $2,784	320 New	320 $2,000
Q1 2020 May 13, 2020	SELL	$1.63 - $3.58 $13 - $28	-8 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$3.15 - $4.67 $132 - $196	-42 Reduced 84.0%	8 $0
Q4 2018 Feb 14, 2019	SELL	$2.95 - $4.15 $2,065 - $2,905	-700 Reduced 93.33%	50 $0
Q3 2018 Nov 14, 2018	SELL	$3.91 - $4.66 $70,239 - $83,712	-17,964 Reduced 95.99%	750 $4,000
Q2 2018 Aug 14, 2018	BUY	$3.86 - $7.61 $61,910 - $122,056	16,039 Added 599.59%	18,714 $92,000
Q1 2018 May 15, 2018	BUY	$6.24 - $9.15 $1,435 - $2,104	230 Added 9.41%	2,675 $21,000
Q4 2017 Feb 14, 2018	BUY	$7.99 - $11.87 $17,154 - $25,484	2,147 Added 720.47%	2,445 $25,000
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $2,720 - $3,492	298	298 $4,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.